Boston- and India-based venture capital firm W Health Ventures is doubling down on its commitment to healthcare innovation with the launch of its second fund, aiming to raise
Boston- and India-based venture capital firm W Health Ventures is doubling down on its commitment to healthcare innovation with the launch of its second fund, aiming to raise $70 million (₹609 crore). Focused on transforming healthcare through technology and innovation, the fund will back early-stage startups in both India and the United States.
With Fund II, W Health is moving beyond the traditional venture capital playbook. The firm aims to take a hands-on, company-building approach—not just investing capital, but actively shaping and supporting ventures from the ground up.
The goal? Solve real, long-standing problems in healthcare by nurturing startups that are purpose-driven, scalable, and built to last.
W Health Ventures was founded in 2019 by Sunil Wadhwani, a serial entrepreneur, healthcare investor, and philanthropist best known for co-founding IGATE, a global IT services company that was acquired by Capgemini.
Wadhwani’s inspiration for launching W Health came from a mix of personal experience, industry insight, and a mission-driven focus on creating long-term impact. His foundation has also been a key player in funding digital public health infrastructure and health access programs across India.
At the helm of W Health Ventures’ day-to-day strategy is Dr. Pankaj Jethwani, the firm’s Managing Partner, who brings a blend of medical expertise, business acumen, and operational leadership. A physician by training, Dr. Jethwani has also served as a healthcare operator and startup advisor before joining W Health.
Speaking about the motivation behind launching Fund II, Dr. Jethwani said:
“We’re in an evergreen sector that will continue to grow at a reasonable pace for the next 20 years. Healthcare innovation in India remains 10–15 years behind global benchmarks. That gap is a generational opportunity.”
It’s a bold statement—but one grounded in reality. From infrastructure gaps to overburdened systems and rising lifestyle-related diseases, the Indian healthcare ecosystem is ripe for disruption. And globally, the sector is in flux, with AI, telemedicine, biotech, and digital health tools transforming the way care is delivered and accessed.
Fund II is W Health’s answer to this complex landscape. The firm plans to support 8–10 high-potential startups over the next four years, offering not just capital but strategic support, domain expertise, and operational guidance.
Unlike conventional VCs that wait for promising decks to land in their inbox, W Health Ventures prefers to be actively involved from the ground up.
This company-building approach means:
The model mirrors the firm’s past success stories. In Fund I, W Health has already backed startups tackling everything from mental health and chronic care to AI-powered diagnostics.
Some of these include:
These companies highlight W Health’s core belief: the future of healthcare lies at the intersection of technology, affordability, and scalability.
Few sectors have witnessed as much transformation—and turmoil—as healthcare in the last five years. The COVID-19 pandemic highlighted systemic weaknesses but also accelerated innovation at an unprecedented rate.
In India, the need for healthcare reform is particularly urgent:
At the same time, digital adoption is booming. Mobile penetration, regulatory support (like Ayushman Bharat Digital Mission), and increasing investor interest have created fertile ground for healthtech startups to scale quickly.
Dr. Jethwani puts it plainly: “India’s healthcare innovation is catching up—but slowly. There’s a massive, untapped opportunity to leapfrog models and bring global-quality care to millions.”
What makes W Health Ventures uniquely positioned is its dual presence in Boston and India. This allows the firm to:
By nurturing startups that can operate and scale in both markets, the firm is betting on a new breed of globally relevant healthtech companies.
W Health Ventures is currently in discussions for the first close of Fund II, expected within the next couple of months. The firm has already started identifying potential ventures that align with its mission of solving high-impact healthcare challenges.
Areas of particular interest include:
The firm’s goal is to keep a tight, high-conviction portfolio, supporting each company with operational, clinical, and capital support over the long term.
In a world where healthcare problems are mounting and solutions often lag, W Health Ventures stands out not just for its capital—but for its conviction.
Fund II is more than a financial instrument. It’s a mission to reshape how healthcare is delivered, who can access it, and how fast innovation reaches those who need it most.
With deep sector knowledge, a proven team, and a clear focus on India and the U.S.—two of the world’s most complex healthcare markets—W Health Ventures is betting that the best healthtech companies of the future are still waiting to be built.
